Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke

This observational study using data from the Get With the Guidelines–Stroke registry investigates the risks and benefits associated with long-term antiplatelet therapy among adult patients with ischemic stroke who receive intravenous tissue plasminogen activator.
Source: JAMA Neurology - Category: Neurology Source Type: research